ExLibris header image
SFX Logo
Title: Mechanism-based corrector combination restores ΔF508-CFTR folding and function
Source:

Nature Chemical Biology [1552-4450] Okiyoneda, Tsukasa yr:2013


Collapse list of basic services Basic
Sorry, no full text available...
Please use the document delivery service (see below)  
Holding information
Holdings in library search engine ALBERT GO
Document delivery
Request document via Library/Bibliothek GO
Users interested in this article also expressed an interest in the following:
1. Negulescu, Paul A. "Correction of the F508del-CFTR protein processing defect in vitro by the investigational drug VX-809." Proceedings of the National Academy of Sciences of the United States of America 108.46 (2011): 18843-18848. Link to Full Text for this item Link to SFX for this item
2. Chiaw, Patrick K. "A chemical corrector modifies the channel function of F508del-CFTR." Molecular pharmacology 78.3 (2010): 411-8. Link to SFX for this item
3. Du, K. "The ΔF508 cystic fibrosis mutation impairs domain-domain interactions and arrests post-translational folding of CFTR." Nature Structural & Molecular Biology 12.1 (2004): 17-25. Link to Full Text for this item Link to SFX for this item
4. Yang, H. "Nanomolar affinity small molecule correctors of defective Delta F508-CFTR chloride channel gating." The Journal of biological chemistry 278.37 (2003): 35079-85. Link to SFX for this item
5. Pedemonte, N. "Small-molecule correctors of defective DeltaF508-CFTR cellular processing identified by high-throughput screening." The journal of clinical investigation 115.9 (2005): 2564-71. Link to Full Text for this item Link to SFX for this item
6. Van Goor, F. "Rescue of CF airway epithelial cell function in vitro by a CFTR potentiator, VX-770." Proceedings of the National Academy of Sciences of the United States of America 106.44 (2009): 18825-18836. Link to Full Text for this item Link to SFX for this item
7. Clancy, Steven P. "Results of a phase IIa study of VX-809, an investigational CFTR corrector compound, in subjects with cystic fibrosis homozygous for the F508del-CFTR mutation." Thorax 67.1 (2011): 12-18. Link to SFX for this item
8. Ramsey, Bonnie W. "A CFTR potentiator in patients with cystic fibrosis and the G551D mutation." The New England journal of medicine 365.18 (2011): 1663-1672. Link to SFX for this item
9. Eckford, Paul D W D. "Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Potentiator VX-770 (Ivacaftor) Opens the Defective Channel Gate of Mutant CFTR in a Phosphorylation-dependent but ATP-independent Manner." Journal of biological chemistry 287.44 (2012): 36639-36649. Link to Full Text for this item Link to SFX for this item
10. Wang, Y. "Understanding how cystic fibrosis mutations disrupt CFTR function: From single molecules to animal models." International journal of biochemistry & cell biology 52 (2014): 47-57. Link to SFX for this item
11. Conese, M. "Gene and cell therapy for cystic fibrosis: from bench to bedside." Journal of cystic fibrosis 10.SUPPL. 2 (2011): -28. Link to SFX for this item
12. Van Goor, F. "Rescue of DeltaF508-CFTR trafficking and gating in human cystic fibrosis airway primary cultures by small molecules." American journal of physiology. Lung cellular and molecular physiology 290.6 (2006): 1117-30. Link to SFX for this item
13. Wellhauser, L. "A small molecule modulator interacts directly with deltaF508-CFTR to modify its ATPase activity and conformational stability." Molecular pharmacology 75.6 (2009): 1430-8. Link to SFX for this item
14. Sheppard, David N. "Structure and function of the CFTR chloride channel." Physiological reviews 79.1 (1999): 23-45. Link to SFX for this item
15. Matsushita, M. "High‐Throughput Screening by Using a Blue‐Fluorescent Antibody Sensor." Angewandte Chemie (International ed. in English) (2003): 5984-. Link to Full Text for this item Link to SFX for this item
16. Bartoszewski, Rafal A. "A synonymous single nucleotide polymorphism in {delta}F508 CFTR alters the secondary structure of the mRNA and the expression of the mutant protein." The Journal of biological chemistry 285.37 (2010): 28741-28748. Link to Full Text for this item Link to SFX for this item
17. Dormer, Fiona L L L. "Benzo(c)quinolizinium drugs inhibit degradation of Delta F508-CFTR cytoplasmic domain." Biochemical and biophysical research communications 300.2 (2003): 524-30. Link to SFX for this item
18. Rocheville, M. "Receptors for Dopamine and Somatostatin: Formation of Hetero-Oligomers with Enhanced Functional Activity." Science 288.5463 (2000): 154-157. Link to SFX for this item
19. Farrell PM, Philip M. "Guidelines for diagnosis of cystic fibrosis in newborns through older adults: Cystic Fibrosis Foundation consensus report." The journal of pediatrics 153.2 (2008): -14. Link to SFX for this item
20. WELSH, MJ J. "DYSFUNCTION OF CFTR BEARING THE DELTA-F508 MUTATION." Journal of cell science 106.SUPPL. 17 (1993): 235-239. Link to SFX for this item
View More...
View Less...
Select All Clear All

Expand list of advanced services Advanced